Third of long COVID patients suffer persistent smell loss, study finds
Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.
Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.
Although young cancer survivors face an elevated risk for later developing cervical, oropharyngeal, and several other human papillomavirus (HPV)–related cancers, HPV vaccination rates among this group remain low…. read more.
According to a new study published in Nursing Outlook, the journal of the American Academy of Nursing, chronic hospital nurse understaffing and poor hospital work environments that predated the Covid-19 pandemic… read more.
Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification[1] against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to… read more.
The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical trials, the antiviral was associated with an 88%… read more.
Surgical masks are not inferior to N95 masks for stopping the spread of COVID-19, says a study led by McMaster University researchers. The results follow the tracking of… read more.
An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by… read more.
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a… read more.
The number of people in Europe dying because of antimicrobial resistant (AMR) infections has hit an all time high, according to new EU data. An estimated 35,000 Europeans… read more.
Children, adolescents and adults have recorded significant new illnesses across 13 distinct diagnosis and symptom complexes after infection with COVID-19, according to a new study published in PLOS Medicine by… read more.
With what some are calling a “tripledemic” of COVID-19, the influenza virus and respiratory syncytial virus, or RSV, soaring in many parts of the country, the holiday season… read more.
A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Researchers from the University… read more.
Advertisment